HSIC peers and competitors
Henry Schein, Inc. · end-of-day data as of Oct 16, 2026
Henry Schein, Inc.
$86.38+1.1%
Buy · 16 analystsPT $91.57 +6.0%
HSIC’s peers by industry and size include McKesson (MCK), Cencora (COR) and Cardinal Health (CAH). Among these 12 companies HSIC ranks 12th by market cap ($9.63B); its P/E of 25.2 compares with a median of 25.6 for its peers.
Peers by industry and size
| 20D | ||||||||
|---|---|---|---|---|---|---|---|---|
| 1 |  | $1,004.84 | +0.6% | 0.0% | -1.5% | 26.9 | $117B | |
| 2 |  | $340.92 | -0.1% | -8.5% | +6.8% | 25.3 | $65.06B | |
| 3 |  | $254.06 | +0.1% | 0.0% | +4.5% | 35.1 | $58.83B | |
| 4 |  | $300.15 | -2.0% | -3.4% | +3.1% | — | $14.46B | |
| 5 |  | $25.28 | -1.9% | -10.8% | -14.8% | — | $13.07B | |
| 6 |  | $187.31 | -1.0% | -22.3% | +24.2% | 16.5 | $11.95B | |
| 7 |  | $72.57 | +0.1% | -0.1% | -7.0% | 62.6 | $11.38B | |
| 8 |  | $57.94 | +0.9% | -31.3% | +0.9% | 19.8 | $11.02B | |
| 9 |  | $185.10 | -1.2% | -23.9% | +11.1% | 7.6 | $10.91B | |
| 10 |  | $147.31 | -1.4% | -25.4% | +35.1% | 25.6 | $10.46B | |
| 11 |  | $141.10 | +1.7% | -59.3% | +32.3% | 26.4 | $9.79B | |
| 12 | | $86.38 | -0.7% | -4.9% | +6.0% | 25.2 | $9.63B |
Data as of Oct 16, 2026 close.